Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.
              
            
            
  
    
      
        Carneiro BA, Konda B, Costa RB, Costa RLB, Sagar V, Gursel DB, Kirschner LS, Chae YK, Abdulkadir SA, Rademaker A, Mahalingam D, Shah MH, Giles FJ.
        
      
    
    Carneiro BA, et al.
    J Clin Endocrinol Metab. 2019 Dec 1;104(12):6193-6200. doi: 10.1210/jc.2019-00600.
    J Clin Endocrinol Metab. 2019.
  
  
  PMID: 31276163
  
  
    
  
  Clinical Trial.